The central government on Friday said that traditional medicines are being developed for prevention and management of vector borne diseases.
Pre-clinical studies for AYUSH PJ7 -- a new drug for dengue -- have been completed, Minister of State for Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) Shripad Yasso Naik said in a written reply to the Lok Sabha.
The minister said that four research councils set up by the Centre are involved in research activities, inter-alia including development and formulation of new drugs.
These research councils are the Central Council for Research in Ayurvedic Sciences (CCRAS), Central Council for Research in Unani Medicine (CCRUM), Central Council for Research in Siddha (CCRS) and Central Council for Research in Homoeopathy (CCRH).
"CCRAS has recently developed AYUSH PJ7 for dengue and AYUSH SL for filarisis. Pre-clinical studies for both the new drugs has been completed," Naik said.
The CCRAS has formulated Ayush 64, a poly herbal, anti-malarial drug, he said and added that it has made deliberations to conduct clinical studies with Indian Council of Medical Research (ICMR) to counter diseases like dengue.
The minister said that CCRUM has made observational studies on the efficacy of some Unani drugs in the vector borne diseases, like malaria, filarisis and Kala Azar which has showed significant therapeutic effects in subsiding different signs and symptoms in these conditions.
"Clinical management studies on dengue, Japanese encephalitis and acute lymphadenitis due to filariasis have already been conducted by CCRH," he added.
--IANS
and/vgu/vt
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
